ADPT vs ZION · rev $142.4M vs P/E 11, rev $354.0M
Adaptive Biotechnologies Corp (ADPT) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
ADPT currently screens at market cap $2.69B. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the ADPT and ZION stock pages for the full models.
Not investment advice.